Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

rhIL-10 reduces liver injury, normalizes serum ALT in HCV patients failing interferon

Nov. 15, 1999

CDP-571 is effective in Crohn's disease: phase IIb study results announced

Nov. 15, 1999

AASLD presentations support feasibility of ribozyme therapy in HCV

Nov. 12, 1999

Phase II data support further study of VX-497 for hepatitis C

Nov. 12, 1999

Preliminary phase II results promising for Maxamine in HCV

Nov. 11, 1999

Dainippon discloses new compounds useful for the treatment or prophylaxis of liver disease

Nov. 10, 1999

Anti-H. pylori compound isolated from Acinetobacter at Takeda laboratories

Nov. 10, 1999

Incara begins clinical program for IBD, explores strategic alternatives

Nov. 9, 1999

TKS-159: metabolism of new GI prokinetic agent and comparison with other benzamides

Nov. 8, 1999

Manipulation of the cytokine pathway: an effective strategy for preventing pancreatitis?

Nov. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...